ZMAX Drug Patent Profile

✉ Email this page to a colleague

When do Zmax patents expire, and when can generic versions of Zmax launch?

Zmax is a drug marketed by Pf Prism Cv and is included in one NDA. There are two patents protecting this drug.

This drug has fifty-one patent family members in forty-three countries.

The generic ingredient in ZMAX is azithromycin. There are thirty-two drug master file entries for this compound. Sixty-two suppliers are listed for this compound. Additional details are available on the azithromycin profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Zmax

A generic version of ZMAX was approved as azithromycin by PLIVA on November 14^th, 2005.

Try a Trial

Summary for ZMAX

International Patents:	51
US Patents:	2
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	74
Patent Applications:	3,137
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for ZMAX
What excipients (inactive ingredients) are in ZMAX?	ZMAX excipients list
DailyMed Link:	ZMAX at DailyMed

Drug patent expirations by year for ZMAX

Anatomical Therapeutic Chemical (ATC) Classes for ZMAX

J01FA	Macrolides
J01F	MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
J01	ANTIBACTERIALS FOR SYSTEMIC USE
J	Antiinfectives for systemic use

S01AA	Antibiotics
S01A	ANTIINFECTIVES
S01	OPHTHALMOLOGICALS
S	Sensory organs

US Patents and Regulatory Information for ZMAX

ZMAX is protected by two US patents.

Patents protecting ZMAX

Azithromycin dosage forms with reduced side effects
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD OF TREATING BACTERIAL INFECTIONS

Multiparticulate crystalline drug compositions having controlled release profiles
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pf Prism Cv	ZMAX	azithromycin	FOR SUSPENSION, EXTENDED RELEASE;ORAL	050797-001	Jun 10, 2005		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial	Y			⤷ Try a Trial
Pf Prism Cv	ZMAX	azithromycin	FOR SUSPENSION, EXTENDED RELEASE;ORAL	050797-001	Jun 10, 2005		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial	Y			⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ZMAX

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pf Prism Cv	ZMAX	azithromycin	FOR SUSPENSION, EXTENDED RELEASE;ORAL	050797-001	Jun 10, 2005	⤷ Try a Trial	⤷ Try a Trial
Pf Prism Cv	ZMAX	azithromycin	FOR SUSPENSION, EXTENDED RELEASE;ORAL	050797-001	Jun 10, 2005	⤷ Try a Trial	⤷ Try a Trial
Pf Prism Cv	ZMAX	azithromycin	FOR SUSPENSION, EXTENDED RELEASE;ORAL	050797-001	Jun 10, 2005	⤷ Try a Trial	⤷ Try a Trial
Pf Prism Cv	ZMAX	azithromycin	FOR SUSPENSION, EXTENDED RELEASE;ORAL	050797-001	Jun 10, 2005	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for ZMAX

See the table below for patents covering ZMAX around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Austria	209497		⤷ Try a Trial
Australia	680356		⤷ Try a Trial
Poland	179910		⤷ Try a Trial
Poland	1537859		⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for ZMAX

Anatomical Therapeutic Chemical (ATC) Classes for ZMAX

Patents protecting ZMAX

Make Better Decisions: Try a trial or see plans & pricing